Predictors of Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection

Daniel M Mandel,Liqi Shu,Christopher Chang,Naomi Jack,Christopher R Leon Guerrero,Nils Henninger,Jayachandra Muppa,Muhammad Affan,Omair Ul Haq Lodhi,Mirjam R Heldner,Kateryna Antonenko,David J Seiffge,Marcel Arnold,Setareh Salehi Omran,Ross Curtiss Crandall,Evan Lester,Diego Lopez Mena,Antonio Arauz,Ahmad Nehme,Marion Boulanger,Emmanuel Touzé,João André Sousa,Joao Sargento-Freitas,Vasco Barata,Paulo Castro-Chaves,Maria Teresa Álvares Pereira Brito,Muhib Khan,dania mallick,Aaron Rothstein,Ossama Khazaal,Josefin E. Kaufmann,Stefan T Engelter,Christopher Traenka,Diana Aguiar de Sousa,Mafalda Soares,Sara DB Rosa,Lily W. Zhou,Preet Gandhi,Thalia S. Field,Steven Mancini,Issa Metanis,Ronen R Leker,Kelly Pan,Vishnu Dantu,Karl Viktor Baumgartner,Tina M Burton,Regina Freiin von Rennenberg,Christian H Nolte,Richard K Choi,Jason A MacDonald,Reza Bavarsad Shahripour,Xiaofan Guo,Malik Ghannam,Mohammad AlMajali,Edgar A. Samaniego,Sebastian Sanchez,Bastien Rioux,Faycal Zine-Eddine,Alexandre Y Poppe,Ana Catarina Fonseca,Maria Fortuna Baptista,Diana Cruz,Michele Romoli,Giovanna De Marco,Marco Longoni,Zafer Keser,Kim J Griffin,Lindsey Kuohn,Jennifer A. Frontera,Jordan Amar,James A Giles,Marialuisa Zedde,Rosario Pascarella,Ilaria Grisendi,Hipólito Nzwalo,David S Liebeskind,Amir M Molaie,Annie Cavalier,Wayneho Kam,Brian Mac Grory,Sami Al Kasab,Mohammad Anadani,Kimberly P Kicielinski,Ali Rada Eltatawy,Lina M. Chervak,Roberto Chulluncuy-Rivas,Yasmin Ninette Aziz,Ekaterina Bakradze,Thanh Lam Tran,Marc Rodrigo-Gisbert,Manuel Requena,Faddi Ghassan Saleh Velez,Jorge G Ortiz Garcia,Varsha Muddasani,Adam de Havenon,Venugopalan Y Vishnu,Sridhara S Yaddanapudi,Latasha Adams,Abigail Browngoehl,Tamra Ranasinghe,Randy Dunston,Zachary Lynch,Mary Penckofer,James E. Siegler,Silvia V Mayer,Joshua Z Willey,Adeel S. Zubair,Yee Kuang Cheng,Richa Sharma,João Pedro Marto,Vitor Mendes Ferreira,Piers Klein,Thanh N. Nguyen,Syed Daniyal Asad,Zoha Sarwat,Anvesh Balabhadra,Shivam Patel,Thais Leite Secchi,Sheila CO Martins,Gabriel Paulo Mantovani,Young Dae Kim,Balaji Krishnaiah,Cheran Elangovan,Sivani Lingam,Abid Y Qureshi,Sebastian Fridman,Alonso Alvarado-Bolaños,Farid Khasiyev,Guillermo Linares,Marina Mannino,Valeria Terruso,Sofia Vassilopoulou,Vasileios Tentolouris-Piperas,MANUEL MARTÍNEZ-MARINO,Víctor A. Carrasco Wall,Fransisca Indraswari,Sleiman El Jamal,Shilin Liu,Muhammad Alvi,Farman Ali,Mohammed Madani Sarvath,Rami Z. Morsi,Tareq Kass-Hout,Feina Shi,Jinhua Zhang,Dilraj Sokhi,Jamil Said,Newnex Mongare,Alexis N. Simpkins,Roberto Gomez,Shayak Sen,Mohammad Ravi Ghani,Marwa Elnazeir,Han Xiao,Narendra Sharma Kala,Farhan Khan,Christoph Stretz,Nahid Mohammadzadeh,Eric D Goldstein,Karen L. Furie,Shadi Yaghi

DOI: https://doi.org/10.1101/2024.08.09.24311773

2024-08-10

Abstract:Objective: Patients with cervical artery dissection (CAD) are at increased ischemic stroke risk. We aimed to identify characteristics that are associated with increased risk of ischemic stroke following initial presentation of CAD and to evaluate the differential impact of anticoagulant versus antiplatelet therapy in these high-risk individuals. Methods: This was a secondary analysis of the Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection (STOP-CAD) study, a multicenter retrospective observational study. The primary outcome was subsequent ischemic stroke by day 180 after diagnosis. Patient characteristics were compared between those with vs. without subsequent ischemic stroke. Significant predictors were identified using stepwise Cox regression. Associations between subsequent ischemic stroke risk and antithrombotic therapy type in high-risk patients were explored using adjusted Cox regression. Results: 4,023 patients (mean age 47.4 years; 44.5% were women) were included. By day 180, 5.3% experienced a subsequent ischemic stroke. In adjusted Cox regression, factors associated with increased subsequent ischemic stroke risk were prior ischemic stroke (aHR 7.31, 95% CI 1.61-33.13, p=0.010), presentation within seven days from symptoms, (aHR 3.04, 95% CI 1.04-8.91, p=0.043), infarct on imaging (aHR 9.85, 95% CI 3.65-26.58, p<0.001), and occlusive dissection (aHR 2.34, 95% CI 1.03-5.34, p=0.043). Only patients with occlusive dissection had reduced subsequent ischemic stroke risk with anticoagulation versus antiplatelets (HR 0.37; 95% CI 0.15-0.89, p=0.03). Interpretation: This study identified several predictors of subsequent ischemic stroke among patients with CAD but only patients with occlusive dissection demonstrated a benefit from anticoagulation. These findings require validation by meta-analyses of prior studies.

Neurology

What problem does this paper attempt to address?

The main objective of this paper is to identify features associated with an increased risk of subsequent ischemic stroke in patients with cervical artery dissection (CAD) and to evaluate the different impacts of anticoagulation therapy compared to antiplatelet therapy in these high-risk individuals.

Specifically, the study was conducted through the following methods:
- **Data Source**: This study is a secondary analysis of the "Antithrombotic Treatment to Prevent Stroke in Cervical Artery Dissection (STOP-CAD)" study. STOP-CAD is a multicenter, retrospective international observational study.
- **Study Population**: A total of 4,023 patients (mean age 47.4 years; 44.5% female) with non-major trauma-related cervical artery dissection were included.
- **Main Outcomes**: Within 180 days of diagnosis, 5.3% of patients experienced subsequent ischemic stroke.
- **Statistical Analysis**: Factors associated with the incidence of subsequent ischemic stroke were initially screened through univariate analysis, followed by stepwise Cox regression analysis to identify significant predictors. Additionally, an adjusted Cox regression model was used to explore the differential impact of anticoagulation versus antiplatelet therapy in patients with high-risk features.

The study results indicate:
- Factors associated with an increased risk of subsequent ischemic stroke include a history of prior ischemic stroke, presentation within 7 days of symptom onset, imaging evidence of infarction, and occlusive dissection.
- Patients with occlusive dissection alone showed a lower risk of subsequent ischemic stroke when treated with anticoagulation therapy.

In summary, this study aims to identify factors that can predict the risk of subsequent ischemic stroke in CAD patients and to explore the effectiveness of different antithrombotic treatment methods. These findings help guide clinicians in managing high-risk patients.